BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20586944)

  • 1. Renal outcomes in chronic kidney disease.
    Iseki K
    Nephrology (Carlton); 2010 Jun; 15 Suppl 2():27-30. PubMed ID: 20586944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between predicted creatinine clearance and proteinuria and the risk of developing ESRD in Okinawa, Japan.
    Iseki K; Kinjo K; Iseki C; Takishita S
    Am J Kidney Dis; 2004 Nov; 44(5):806-14. PubMed ID: 15492946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of single measurements of dipstick proteinuria, estimated glomerular filtration rate, and hematocrit with 25-year incidence of end-stage renal disease in the multiple risk factor intervention trial.
    Ishani A; Grandits GA; Grimm RH; Svendsen KH; Collins AJ; Prineas RJ; Neaton JD
    J Am Soc Nephrol; 2006 May; 17(5):1444-52. PubMed ID: 16611715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of high fasting plasma glucose and risk of developing end-stage renal disease in screened subjects in Okinawa, Japan.
    Iseki K; Ikemiya Y; Kinjo K; Iseki C; Takishita S
    Clin Exp Nephrol; 2004 Sep; 8(3):250-6. PubMed ID: 15480903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Epidemiology of CKD in Japan].
    Iseki K
    Nihon Rinsho; 2008 Sep; 66(9):1650-6. PubMed ID: 18788390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic kidney disease in Japan from early predictions to current facts.
    Iseki K
    Nephron Clin Pract; 2008; 110(4):c268-72. PubMed ID: 18997469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic Kidney Disease Japan Cohort (CKD-JAC) study: design and methods.
    Imai E; Matsuo S; Makino H; Watanabe T; Akizawa T; Nitta K; Iimuro S; Ohashi Y; Hishida A;
    Hypertens Res; 2008 Jun; 31(6):1101-7. PubMed ID: 18716357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort.
    Iseki K; Ikemiya Y; Inoue T; Iseki C; Kinjo K; Takishita S
    Am J Kidney Dis; 2004 Oct; 44(4):642-50. PubMed ID: 15384015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
    Grabysa R; Cholewa M
    Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease in long-term survivors of myeloablative allogeneic haematopoietic cell transplantation: prevalence and risk factors.
    Ando M; Ohashi K; Akiyama H; Sakamaki H; Morito T; Tsuchiya K; Nitta K
    Nephrol Dial Transplant; 2010 Jan; 25(1):278-82. PubMed ID: 19762604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syndrome of rapid-onset end-stage renal disease: a new unrecognized pattern of CKD progression to ESRD.
    Onuigbo MA
    Ren Fail; 2010; 32(8):954-8. PubMed ID: 20722563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prevention and screening of chronic renal failure].
    Bourel M; Ardaillou R
    Bull Acad Natl Med; 2004; 188(8):1455-68. PubMed ID: 15918671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The natural history of chronic kidney disease revisited--a 72-month Mayo Health System Hypertension Clinic practice-based research network prospective report on end-stage renal disease and death rates in 100 high-risk chronic kidney disease patients: a call for circumspection.
    Onuigbo MA
    Adv Perit Dial; 2009; 25():85-8. PubMed ID: 19886324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes in CKD: what we know and what we need to know.
    Clark LE; Khan I
    Nephron Clin Pract; 2010; 114(2):c95-102. PubMed ID: 19887829
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of developing low glomerular filtration rate or elevated serum creatinine in a screened cohort in Okinawa, Japan.
    Iseki K; Iseki C; Ikemiya Y; Kinjo K; Takishita S
    Hypertens Res; 2007 Feb; 30(2):167-74. PubMed ID: 17460387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Early diagnosis of chronic kidney disease. New insights into creatinine and proteinuria].
    Brandenburg V; Floege J
    Med Klin (Munich); 2006 Mar; 101 Suppl 1():158-62. PubMed ID: 16802544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing the development of end-stage renal disease.
    Iseki K
    Clin Exp Nephrol; 2005 Mar; 9(1):5-14. PubMed ID: 15830267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan.
    Chiu YL; Chien KL; Lin SL; Chen YM; Tsai TJ; Wu KD
    Nephron Clin Pract; 2008; 109(3):c109-18. PubMed ID: 18663322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increasing gender difference in the incidence of chronic dialysis therapy in Japan.
    Iseki K; Nakai S; Shinzato T; Nagura Y; Akiba T;
    Ther Apher Dial; 2005 Oct; 9(5):407-11. PubMed ID: 16202016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.